Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits

British Journal of Cancer

Volumn 79, Issue 1, 1999, Pages 114-118

  Verheul, H M W ^a   Panigrahy, D ^a   Yuan, J ^a   D'Amato, R J ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Basic fibroblast growth factor; Corneal neovascularization; Cyclo oxygenase; Non steroidal anti inflammatory drug; Vascular endothelial growth factor

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; ESCULETIN; IBUPROFEN; INDOMETACIN; KETOPROFEN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NORDIHYDROGUAIARETIC ACID; PARACETAMOL; PHENIDONE; PROADIFEN; QUERCETIN; SULINDAC; SULINDAC SULFIDE; THALIDOMIDE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOMA; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; CORNEA; FEMALE; MALE; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RABBITS; SULINDAC; THALIDOMIDE;

EID: 0032889225     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690020     Document Type: Article

References (42)

1. Bossi P, Viale G, Lee AKC, Alfano RM, Coggi G and Bosari S (1995) Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res 55: 5049-5053
2. Chiu C, McEntee MF and Whelan J (1997) Sulindac causes rapid regression of preexisting tumors in Min/+ mice, independent of prostaglandin biosynthesis. Cancer Res 57: 4267-4273
3. D'Amato RJ, Loughnan MS, Flynn E and Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91: 4082-4085
4. Duggan DE, Hooke KF, Risley EA, Shen TY and van Arman CG (1977) Identification of the biologically active form of sulindac. J Pharm Exp Ther 201: 8-13
5. Fine HA (1997) A phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas (abstract). In Thalidomide: Potential Benefits and Risks, Open Public Scientific Workshop, p. 85. National Institute of Health: Bethesda, MD
6. Folkman J (1975) Tumor angiogenesis: a possible control point in tumor growth. Ann Intern Med 82: 96-100
7. Folkman J (1989) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6
8. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27-31
9. Folkman J (1997) Antiangiogenic therapy. In Cancer, Principles and Practice of Oncology. DeVita Jr VT, Hellman S and Rosenberg SA (eds), pp. 3075-3086. Lipincott Raven: New York
10. Folkman J and Ingber DE (1987) Angiostatic steroids: method of discovery and mechanism of action. Ann Surg 206: 374-384
11. Fulton AM (1984) In vivo effects of indomethacin on the growth of murine mammary tumors. Cancer Res 44: 2419-2420
12. Giardiello FM, Hamilton SR, Krush AJ, Piantodosi S, Hylind LM, Cleano P, Banker SV, Robinson CR and Offerhaus GJ (1993) Treatment of colonic rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328: 1313-1316
13. Gross J, Azizkhan RG, Biswas C, Bruns RR, Hsieh DST and Folkman J (1981) Inhibition of tumor growth, vasularization, and collagenolysis in the rabbit cornea by medroxyprogesterone. Proc Natl Acad Sci USA 78: 1176-1180
14. Gutman M, Szold A, Ravid A, Lazouskas T, Merimsky O and Klausner JM (1996) Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo. Anticancer Res 16: 3673-3678
15. Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SI and Rigos B (1996) Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 52: 237-245
16. Haynes WL, Proia AD and Klintworth GK (1989) Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat. Invest Ophthalmol Vis Sci 30: 1588-1593
17. Hudson N, Balsitis M, Everitt S and Hawkey CJ (1995) Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal anti-inflammatory drugs. Gut 37: 191-194
18. Insel PA (1996) Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In The Pharmacological Basis of Therapeutics. Hardman JG and Limbird LE (eds), pp. 617-658. The McGraw-Hill Companies: New York
19. Kamei S, Okada H, Inoue Y, Yoshioka T, Ogawa Y and Toguchi H (1993) Antitumor effects of angiogenesis inhibitor TNP-470 in rabbits bearing VX-2 carcinoma by arterial administration of microspheres and oil solution. J Pharm Exp Ther 264: 469-474
20. Karim S, Habib A, Levy-Toledano S and Maclouf J (1995) Cyclooxygenases-1 and -2 of endothelial cells utilize exogenous or endogenous arachidonic acid for transcellular production of thromboxane. J Biol Chem 271: 12042-12048
21. Kenyon BM, Voest EE, Chen C, Flynn E, Folkman J and D'Amato RJ (1996) A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 37: 1625-1632
22. Kenyon BM, Browne F and D'Amato RJ (1997) Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp Eye Res 64: 971-978
23. Kidd JG and Rous P (1940) A transplantable rabbit carcinoma originating in a virus-induced papilloma and containing the virus in masked or altered form. J Exp Med 71: 813-838
24. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, Duhamel A, Transset M and Attali P (1991) Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101: 635-639
25. Little R, Welles L, Wyvill K, Pluda J, Figg W, Tosato G and Yarchoan R (1997) Preliminary results of a phase II dose titration study of oral thalidomide in patients with HIV infection and Kaposi's sarcoma (abstract). In Thalidomide: Potential Benefits and Risks, Open Public Scientific Workshop, p. 91. National Institute of Health: Bethesda, MD
26. Lynch NR, Castes M, Astoin M and Salomon JC (1978) Mechanism of inhibition of tumour growth by aspirin and indomethacin. Br J Cancer 38: 503-512
27. Marnett LJ (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575-5589
28. Meade EA, Smith WL and DeWitt DL (1993) Differential inhibition of prostaglandin endoperoxide synthetase (cyclooygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 268: 6610-6614
29. Minchinton AI, Fryer KH, Wendt KR, Clow KA and Hayes MMM (1996) The effect of thalidomide on experimental tumors and metastases. Anticancer Drugs 7: 339-343
30. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ and Vane JR (1993) Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90: 11693-11697
31. Peterson H (1996) Tumor angiogenesis inhibition by prostaglandin synthetase inhibitors. Anticancer Res 6: 251-254
32. Piazza GA, Rahm AL, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts OS and Paniukou R (1997) Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 55: 3110-3116
33. Pliess G (1962) Thalidomide and congenital abnormalities. Lancet 2: 1128-1129
34. Sakamoto T, Soriano D, Nassaralla J, Murphy TL, Oganesian A, Spee C, Hinton DR and Ryan SJ (1995) Effect of intravitreal administration of indomethacin on experimental subretinal neovascularization in the subhuman primate. Arch Ophthamol 113: 222-226
35. Schumacher H, Smith RL and Williams RT (1965) Metabolism of thalidomide: the fate of thalidomide and some of its hydrolysis products in various species. Br J Pharmacol 25: 338-351
36. Schumacher H, Blake DA and Gilette JR (1968) Disposition of thalidomide in rabbits and rats. J Pharm Exp Ther 160: 201-211
37. Silverman KJ, Lund DP, Zetter BR, Lainey LL, Shahood JA, Freiman DG, Folkman J and Burger AC (1988) Angiogenic activity of adipose tissue. Biochem Biophys Res Commun 153: 347-352
38. Smith WL, Meade EA and DeWitt DL (1994) Interactions of PGH synthase isozymes-1 and -2 with NSAIDs. Ann NY Acad Sci 744: 50-57
39. Szabo KT and Steelman RL (1967) Effects of maternal thalidomide treatment on pregnancy, fetal development, and mortality of the offspring in random-bred mice. Am J Vet Res 28: 1823-1828
40. Tanaka H, Sukhova GK and Libby P (1994) Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. Arteriosclerosis Thromb 14: 734-745
41. Teicher BA, Korbut TT, Menon K, Holden SA and Ara G (1994) Cyclooxygenase and lipoxygenase as modulators of cancer therapies. Cancer Chem Pharm 33: 515-522
42. Weidner N, Semple JP, Welch WR and Folkman J (1991) Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8